← Open Payments lookup

KATHY THOMAS: Open Payments

NPI 1396159026 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$294 in 12 payments from 6 companies in 2025. Trend: 2023 $433 · 2024 $376 · 2025 $294

Food & beverage: $294
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation5$130
Bayer Healthcare Pharmaceuticals Inc.3$79
Novo Nordisk Inc1$24
GlaxoSmithKline, LLC.1$23
Daiichi Sankyo Inc.1$22
Boehringer Ingelheim Pharmaceuticals, Inc.1$16

Products named: Fabhalta, Kerendia, Vanrafia, Ozempic, SHINGRIX, INJECTAFER, JARDIANCE.

Industry payments across MS — which companies pay providers there.